Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
313 studies found for:    UVEITIS
Show Display Options
Rank Status Study
1 Recruiting Genetics of Uveitis
Conditions: Uveitis;   Infectious Uveitis
Intervention:
2 Active, not recruiting Study of the Safety, Tolerability, and Bioactivity of Tocilizumab On Patients With Non-infectious UVEITIS: The STOP-UVEITIS Study
Conditions: Intermediate Uveitis;   Posterior Uveitis;   Pan-uveitis
Intervention: Drug: Tocilizumab
3 Active, not recruiting Study of H.P. ACTHAR Subcutaneous Gelatin (Gel)(Highly Purified Gel Injection) in Uveitis Patients
Conditions: Uveitis;   Anterior Uveitis;   Intermediate Uveitis;   Posterior Uveitis;   Scleritis;   Clinically Significant Macular Edema
Intervention: Drug: H.P. ACTHAR SUBCUTANEOUS GEL INJECTION
4 Active, not recruiting A Study of the Long-term Safety and Efficacy of Adalimumab in Subjects With Intermediate-, Posterior-, or Pan-uveitis
Condition: Uveitis
Intervention: Drug: adalimumab
5 Recruiting Study of the Effectiveness of Ozurdex for the Control of Uveitis
Conditions: Uveitis, Intermediate;   Uveitis, Posterior
Intervention: Drug: Dexamethasone pellet
6 Completed
Has Results
Multicenter Uveitis Steroid Treatment (MUST) Trial
Condition: Uveitis
Interventions: Drug: fluocinolone acetonide intraocular implant;   Drug: oral corticosteroid with immunosuppressive agents as needed
7 Completed Evaluation of a Standardized Strategy for Uveitis Etiological Diagnosis
Condition: Uveitis
Interventions: Other: Free strategy;   Other: Standardized strategy
8 Active, not recruiting Optical Coherence Tomography (OCT) in Uveitis
Condition: Uveitis
Intervention:
9 Not yet recruiting Open Label Study of Acthar SQ Gel Injection in Patients With Active Anterior Uveitis
Condition: Uveitis
Intervention: Drug: Acthar
10 Completed Suprachoroidal Injection of Triamcinolone Acetonide in Subjects With Macular Edema Following Non-Infectious Uveitis
Conditions: Uveitis;   Macular Edema;   Uveitis, Posterior;   Uveitis, Anterior;   Panuveitis;   Uveitis, Intermediate
Interventions: Drug: 4 mg CLS-TA;   Drug: 0.8 mg CLS-TA
11 Completed
Has Results
Optiquel® as Corticosteroid-sparing Therapy for Chronic Noninfectious Uveitis
Condition: Uveitis
Interventions: Drug: B27PD;   Drug: Placebo
12 Completed Randomized, Controlled Trial to Test the Efficacy of Interferon Beta in the Treatment of Intermediate Uveitis
Conditions: Uveitis, Intermediate;   Macular Edema;   Multiple Sclerosis
Interventions: Drug: Interferon beta;   Drug: Methotrexate
13 Completed Infectious Causes of Uveitis
Condition: Uveitis
Intervention:
14 Not yet recruiting Safety &Efficacy of CF101 to Subjects With Uveitis
Conditions: Uveitis, Posterior;   Uveitis, Intermediate
Interventions: Drug: CF101;   Drug: Placebo
15 Unknown  Sirolimus as Therapeutic Approach to Uveitis
Conditions: Uveitis;   Intermediate Uveitis;   Posterior Uveitis;   Panuveitis
Intervention: Drug: Sirolimus (rapamycin)
16 Completed Intravitreal Infliximab in Refractory Uveitis in Behcet's Disease: A Safety and Efficacy Clinical Study
Conditions: Behçet's Disease;   Uveitis
Intervention: Drug: Intravitreal Infliximab
17 Completed Effect of Adalimumab for the Treatment of Uveitis in Juvenile Idiopathic Arthritis
Conditions: Uveitis;   Juvenile Arthritis
Interventions: Drug: Anti-tumor necrosis factor alpha monoclonal antibody;   Drug: placebo
18 Active, not recruiting Clinical Outcome in Uveitis
Condition: Uveitis
Intervention:
19 Recruiting Microbiological Diagnosis of Infectious Uveitis to Pathogenic Fastidious Germs
Condition: Uveitis
Intervention: Other: Blood sampling
20 Recruiting Safety and Efficacy Study of DSP-Visulex for the Treatment of Anterior Uveitis
Condition: Non-Infectious Anterior Uveitis
Interventions: Drug: 8% Dexamethasone Sodium Phosphate - Visulex;   Drug: 15% Dexamethasone Sodium Phosphate - Visulex;   Drug: Prednisolone Acetate (1%) Eye Drops

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years